Top Markets
Coin of the day
Bioqual, Inc. Bioqual, Inc.

Bioqual, Inc.

BIOQ
株式のランク #28020
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing... Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.
株価
$32.50
最終同期: 2026-08-18
時価総額
$29.07M
変化(1日)
0.00%
変化(1年)
-24.75%
US
取引 Bioqual, Inc. (BIOQ)

カテゴリー

Bioqual, Inc.(BIOQ)のP/S比率
2026 時点のP/S比率 TTM: 0
Bioqual, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Bioqual, Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率